<ul data-eligibleForWebStory="false"><li>Plexāā, a UK-based MedTech startup, closes $4.5M funding extension round led by TCP Health Ventures to bring its BLOOM⁴³ medical device for breast surgery to the U.S.</li><li>The funding includes investments from existing and new investors, i4i grant funding, and support from Thena Capital, a London-based VC firm focused on digital health.</li><li>BLOOM⁴³ is a wearable device for breast cancer surgery utilizing Supraphysiological Preconditioning to reduce complication rates and improve surgical readiness.</li><li>Plexāā aims to make prehabilitation and preconditioning the standard of care for surgery, expand to other surgical fields, and enhance patient outcomes globally.</li></ul>

Plexāā Closes $4.5M Extension to Bring Wearable Device for Breast Cancer Surgery to U.S.

Discover more